Metadata from OpenAlexLast checked: Sep 26, 2026

EJNMMI Radiopharmacy and Chemistry — Journal Profile & Submission Links

Springer Nature · ISSN-L 2365-421X

Source-backed journal profile with OpenAlex metadata and links to official submission resources for EJNMMI Radiopharmacy and Chemistry.

This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.

Official links

Publisher
Springer Nature
Country
GB
Open access
Yes
Listed in DOAJ
Yes
APC (USD)
—
Works count
492
Cited-by count
7154
OpenAlex 2-year mean citedness
3.99
Quartile
Q2

Catalog scope notes

EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists, biologists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel production methods of radionuclides, novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To foster daily practice in the community the journal stimulates submission regarding best practice and harmonization of methodologies. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers. To further serve the community the journal publishes abstracts of radiopharmaceutical-oriented congresses.

Catalog source: scimago. This is not a copy of the publisher's author instructions.

Submission & timeline

Submission portal
Information not currently available.
Average review time
Information not currently available.
Acceptance rate
Information not currently available.
Article types accepted
Information not currently available.
Publication frequency
Information not currently available.

General pre-submission checks for medical manuscripts

Generic checklist only — not journal-specific requirements.

  • Confirm scope fit and intended article type on the official journal site.
  • Abstract structure matches the journal's current requirements.
  • Ethics approval and trial registration statements are complete.
  • Informed consent and patient privacy statements are in place.
  • Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
  • Reference style and citation limits per official guidelines.
  • Figures and tables meet resolution, labeling, and count limits.
  • Cover letter addresses novelty, fit, and required declarations.
  • Conflicts of interest statement included.
  • Funding statement included.
  • Data availability statement included when required.

FAQ

EJNMMI Radiopharmacy and Chemistry Submission Guide